Evogene Ltd (EVGN)
0.8499
+0.15
(+21.41%)
USD |
NASDAQ |
May 10, 10:44
Evogene Shareholders Equity (Quarterly): 12.05M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.05M |
| September 30, 2023 | 18.51M |
| June 30, 2023 | 14.29M |
| March 31, 2023 | 22.09M |
| December 31, 2022 | 27.93M |
| September 30, 2022 | 30.58M |
| June 30, 2022 | 36.95M |
| March 31, 2022 | 45.53M |
| December 31, 2021 | 53.65M |
| September 30, 2021 | 60.69M |
| June 30, 2021 | 66.40M |
| March 31, 2021 | 71.54M |
| December 31, 2020 | 46.04M |
| September 30, 2020 | 44.93M |
| June 30, 2020 | 39.76M |
| March 31, 2020 | 43.98M |
| December 31, 2019 | 50.14M |
| September 30, 2019 | 56.09M |
| June 30, 2019 | 42.59M |
| March 31, 2019 | 46.53M |
| December 31, 2018 | 50.05M |
| September 30, 2018 | 55.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 59.95M |
| March 31, 2018 | 64.35M |
| December 31, 2017 | 69.38M |
| September 30, 2017 | 75.00M |
| June 30, 2017 | 79.34M |
| March 31, 2017 | 83.31M |
| December 31, 2016 | 87.29M |
| September 30, 2016 | 93.28M |
| June 30, 2016 | 97.69M |
| March 31, 2016 | 101.34M |
| December 31, 2015 | 103.75M |
| September 30, 2015 | 108.09M |
| June 30, 2015 | 110.35M |
| March 31, 2015 | 113.69M |
| December 31, 2014 | 116.08M |
| September 30, 2014 | 120.29M |
| June 30, 2014 | 121.83M |
| March 31, 2014 | 123.93M |
| December 31, 2013 | 124.75M |
| September 30, 2013 | 46.41M |
| June 30, 2013 | 47.30M |
| December 31, 2012 | 48.26M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.05M
Minimum
Dec 2023
71.54M
Maximum
Mar 2021
41.25M
Average
43.98M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd | 65.56M |
| Pluri Inc | 4.399M |
| BioLine Rx Ltd | 13.22M |
| Can Fite Biofarma Ltd | 6.243M |
| BiomX Inc | 3.081M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.10M |
| Total Liabilities (Quarterly) | 22.42M |
| Debt to Equity Ratio | 0.8602 |
| Current Ratio | 4.964 |
| Net Debt Paydown Yield | -0.17% |